BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1195 related articles for article (PubMed ID: 20404615)

  • 41. Prognostically orientated multimodality treatment including surgery for selected patients of small-cell lung cancer patients stages IB to IIIB: long-term results of a phase II trial.
    Eberhardt W; Stamatis G; Stuschke M; Wilke H; Müller MR; Kolks S; Flasshove M; Schütte J; Stahl M; Schlenger L; Budach V; Greschuchna D; Stüben G; Teschler H; Sack H; Seeber S
    Br J Cancer; 1999 Dec; 81(7):1206-12. PubMed ID: 10584883
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of the new lung cancer staging system for a predominantly advanced-disease patient population.
    Chien CR; Yang ST; Chen CY; Fang HY; Tu CY; Tseng GC; Yu YH; Chen HJ; Ho CT; Hsieh CY; Chen HN; Chen PR; Liu JC; Wang YC; Wu HH; Hsia TC
    J Thorac Oncol; 2010 Mar; 5(3):340-3. PubMed ID: 20186024
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The present status of surgery for lung cancer.
    Lacquet LK
    Acta Chir Belg; 1996; 96(6):245-51. PubMed ID: 9008764
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Can extracapsular lymph node involvement be a tool to fine-tune pN1 for adenocarcinoma of the oesophagus and gastro-oesophageal junction in the Union Internationale contre le Cancer (UICC) TNM 7th edition?†.
    Nafteux P; Lerut T; De Hertogh G; Moons J; Coosemans W; Decker G; Van Veer H; De Leyn P
    Eur J Cardiothorac Surg; 2014 Jun; 45(6):1001-10. PubMed ID: 24477743
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
    Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New TNM classification for non-small-cell lung cancer.
    Tanoue LT; Detterbeck FC
    Expert Rev Anticancer Ther; 2009 Apr; 9(4):413-23. PubMed ID: 19374596
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Postoperative prognosis in patients with non-small cell lung cancer with synchronous ipsilateral intrapulmonary metastasis.
    Yoshino I; Nakanishi R; Osaki T; Hasuda S; Taga S; Takenoyama M; Yoshimatsu T; Yasumoto K
    Ann Thorac Surg; 1997 Sep; 64(3):809-13. PubMed ID: 9307478
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Validation of the prognostic value of new sub-stages within the AJCC 8th edition of non-small cell lung cancer.
    Abdel-Rahman O
    Clin Transl Oncol; 2017 Nov; 19(11):1414-1420. PubMed ID: 28497423
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Japanese Lung Cancer Registry Study: first prospective enrollment of a large number of surgical and nonsurgical cases in 2002.
    Sawabata N; Asamura H; Goya T; Mori M; Nakanishi Y; Eguchi K; Koshiishi Y; Okumura M; Miyaoka E; Fujii Y;
    J Thorac Oncol; 2010 Sep; 5(9):1369-75. PubMed ID: 20683209
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic value of the 7th AJCC/UICC TNM classification of noncardia gastric cancer: analysis of a large series from specialized Western centers.
    Marrelli D; Morgagni P; de Manzoni G; Coniglio A; Marchet A; Saragoni L; Tiberio G; Roviello F;
    Ann Surg; 2012 Mar; 255(3):486-91. PubMed ID: 22167003
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Non-small cell lung cancer staging: proposed revisions to the TNM system.
    Schneider BJ
    Cancer Imaging; 2008 Sep; 8(1):181-5. PubMed ID: 18824424
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Validation of the lung cancer staging system revisions using a large prospective clinical trial database (ACOSOG Z0030).
    Fibla JJ; Cassivi SD; Decker PA; Allen MS; Darling GE; Landreneau RJ; McKenna RJ; Putnam JB;
    Eur J Cardiothorac Surg; 2013 May; 43(5):911-4. PubMed ID: 23014970
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of clinical and pathological tumor, node and metastasis staging of lung cancer: 15-year experience with 530 patients.
    Turk F; Gursoy S; Yaldiz S; Yuncu G; Yazgan S; Basok O
    Minerva Chir; 2011 Dec; 66(6):509-16. PubMed ID: 22233657
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is the new seventh AJCC/UICC staging system appropriate for patients with gastric cancer?
    Yoon HM; Ryu KW; Nam BH; Cho SJ; Park SR; Lee JY; Lee JH; Kook MC; Choi IJ; Kim YW
    J Am Coll Surg; 2012 Jan; 214(1):88-96. PubMed ID: 22036661
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of 6th and 7th AJCC TNM staging classification for carcinoma of the stomach in China.
    Qiu MZ; Wang ZQ; Zhang DS; Liu Q; Luo HY; Zhou ZW; Li YH; Jiang WQ; Xu RH
    Ann Surg Oncol; 2011 Jul; 18(7):1869-76. PubMed ID: 21246404
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Proteomic analysis of resectable non-small cell lung cancer: post-resection serum samples may be useful in identifying potential markers.
    Rathinam S; Ward DG; James ND; Rajesh PB
    Interact Cardiovasc Thorac Surg; 2011 Jul; 13(1):3-6. PubMed ID: 21525028
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Proposed modification of the seventh American Joint Committee on Cancer staging system for esophageal squamous cell carcinoma in Chinese patients.
    Hou X; Wei JC; Fu JH; Wang X; Zhang LJ; Lin P; Yang HX
    Ann Surg Oncol; 2014 Jan; 21(1):337-42. PubMed ID: 24046121
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of clinical and surgical-pathological staging in IIIA non-small cell lung cancer patients.
    Muehling B; Wehrmann C; Oberhuber A; Schelzig H; Barth T; Orend KH
    Ann Surg Oncol; 2012 Jan; 19(1):89-93. PubMed ID: 21755379
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of 7th and 8th editions of the UICC/AJCC TNM staging for non-small cell lung cancer in a non-metastatic North American cohort undergoing primary radiation treatment.
    Koul R; Rathod S; Dubey A; Bashir B; Chowdhury A
    Lung Cancer; 2018 Sep; 123():116-120. PubMed ID: 30089581
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Features and prognostic factors of large node-negative non-small-cell lung cancers shifted to stage II.
    Toffalorio F; Radice D; Spaggiari L; Sinno V; Barberis M; Spitaleri G; Giovannini M; Delmonte A; Catania C; Noberasco C; Brambilla D; de Braud F; Veronesi G; Solli P; De Pas T
    J Thorac Oncol; 2012 Jul; 7(7):1124-30. PubMed ID: 22610258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 60.